Workflow
icon
Search documents
钢铁周报:需求季节性走弱,限产预期托底
ZHESHANG SECURITIES· 2025-06-09 01:13
Investment Rating - The industry investment rating is "Positive" [1] Core Viewpoints - Seasonal demand is weakening, but production restrictions are expected to provide support [1] - The report highlights that the overall inventory of five major steel products is 9.3 million tons, with a year-to-date increase of 22.7% [5] - The total inventory at steel mills is 4.33 million tons, reflecting a year-to-date increase of 23.6% [5] - Iron ore port inventory stands at 13.83 million tons, with a year-to-date increase of 6.9% [5] Price Trends - The SW Steel Index is at 2,119, with a weekly change of -0.2% and a year-to-date change of 0.8% [3] - Rebar (HRB400 20mm) price is 3,140 CNY/ton, with a weekly increase of 0.3% and a year-to-date increase of 7.9% [3] - Hot-rolled coil price is 3,097 CNY/ton, with a weekly increase of 0.1% and a year-to-date decrease of 9.5% [3] - Cold-rolled steel price is 3,640 CNY/ton, with a weekly increase of 2.8% and a year-to-date increase of 11.4% [3] Supply and Demand - The average daily pig iron output is projected to be around 230,000 tons [9] - The report indicates that the steel mills' operating rate is fluctuating, impacting overall production [12] - The apparent demand for rebar is noted to be significant, with ongoing monitoring of market conditions [14]
浙商早知道-20250609
ZHESHANG SECURITIES· 2025-06-08 23:40
证券研究报告 | 浙商早知道 报告日期:2025 年 06 月 09 日 浙商早知道 2025 年 06 月 09 日 :张延兵 执业证书编号:S1230511010020 :021-80106048 :zhangyanbing@stocke.com.cn 重要推荐 【浙商计算机 刘雯蜀/童非】优刻得(688158)公司深度:从响应 DeepSeek 看优刻得,云计算价值重估进行时— —20250606 重要观点 http://www.stocke.com.cn 1/5 请务必阅读正文之后的免责条款部分 【浙商 ESG 祁星】深度研究:ESG 体系下的 AI 研究(一):多维投资增效,防范伦理风险——20250605 【浙商固收 覃汉/陈婷婷】债券市场专题研究:对于 6 月资金面的思考——20250605 【浙商固收 覃汉/郑莎】债券市场专题研究:近期焦煤上涨对债市是否有影响? ——20250606 【浙商策略 廖静池/王大霁/李沛】A 股策略周报:"上下两难"盘面焦灼,持原仓、盯券商——20250607 1.1 【浙商计算机 刘雯蜀/童非】优刻得(688158)公司深度:从响应 DeepSeek 看优刻得, ...
智翔金泰点评报告:赛立奇商业化,多管线兑现期
ZHESHANG SECURITIES· 2025-06-08 13:25
Investment Rating - The investment rating for the company is "Buy" [7] Core Viewpoints - The report is optimistic about the commercialization prospects of the company's products, including the monoclonal antibody "Sai Li Qi" and the bispecific antibodies GR2002 and GR1803, anticipating data readouts that could enhance valuation [1] - The company achieved significant revenue growth in 2024, with total revenue reaching 30.10 million yuan, and a slight narrowing of net losses to 797 million yuan [1] - The company has a differentiated pipeline with key products progressing steadily, including the approval of Sai Li Qi for moderate to severe plaque psoriasis and ankylosing spondylitis [1][2] Financial Performance - In Q1 2025, the company reported revenue of 20.16 million yuan and a net loss of 121 million yuan, with R&D expenses at 10.30 million yuan [1] - Revenue projections for 2025-2027 are estimated at 199 million yuan, 533 million yuan, and 1.07 billion yuan respectively, reflecting a strong growth trajectory [4][6] - The company maintains high R&D expenditure, with 610 million yuan in 2024, indicating a commitment to innovation [1] Pipeline Development - The GR1802 monoclonal antibody is progressing through clinical trials for multiple indications, with significant market potential [2] - The GR1801 rabies virus antibody is currently under review for market approval, with promising commercial prospects [2] - Other pipeline products, including GR2001 and GR1803, are advancing through clinical stages and partnerships, demonstrating the company's innovative capabilities [3]
6 月中旬:边际乐观,逢低建仓——主动量化周报
ZHESHANG SECURITIES· 2025-06-08 13:15
Quantitative Models and Construction Methods 1. Model Name: Annualized Discount Model for CSI 500 Futures - **Model Construction Idea**: The model identifies optimal entry points for building positions based on historical performance when the annualized discount of CSI 500 futures exceeds a certain threshold, indicating market pessimism. [1][11] - **Model Construction Process**: - The model uses the annualized discount rate of the next-month contract of CSI 500 index futures as the key metric. - Historical data from 2017 onwards is analyzed to determine the relationship between the discount rate and subsequent returns. - Key findings: - When the annualized discount exceeds 15%, holding the index for more than 12 trading days results in average cumulative returns trending upward. - Holding for over 33 trading days yields a probability of positive cumulative returns exceeding 50%. - Holding for over 50 trading days increases the probability of positive returns to approximately 60%. - Formula: $ \text{Annualized Discount} = \frac{\text{Spot Price} - \text{Futures Price}}{\text{Futures Price}} \times \frac{365}{\text{Days to Maturity}} $ - Spot Price: Current index level - Futures Price: Price of the futures contract - Days to Maturity: Remaining days until the futures contract expires [11] - **Model Evaluation**: The model effectively captures market pessimism and identifies potential rebound opportunities, making it a useful tool for timing market entry. [11] --- Model Backtesting Results 1. Annualized Discount Model for CSI 500 Futures - **Key Metrics**: - Holding for 12 trading days: Average cumulative returns trend upward. - Holding for 33 trading days: Positive return probability > 50%. - Holding for 50 trading days: Positive return probability ~60%. [1][11] --- Quantitative Factors and Construction Methods 1. Factor Name: Proprietary Active Trader Activity Indicator - **Factor Construction Idea**: This factor measures the activity level of speculative funds (e.g., proprietary traders) to gauge market sentiment and risk appetite. [3][13] - **Factor Construction Process**: - Data Source: Derived from "Dragon and Tiger List" (龙虎榜) data. - The indicator tracks the marginal changes in active trader participation over time. - Observations: - From late April, the indicator showed a consistent decline, reflecting reduced risk appetite and cautious market sentiment. - Recently, the indicator has shown marginal improvement, suggesting a potential rebound in risk appetite. [3][13] - **Factor Evaluation**: The factor provides timely insights into the behavior of speculative funds, which can serve as a leading indicator for shifts in market sentiment. [3][13] 2. Factor Name: BARRA Style Factors - **Factor Construction Idea**: These factors assess the performance of various style attributes (e.g., momentum, volatility, size) to understand market preferences. [23][24] - **Factor Construction Process**: - Data Source: BARRA factor model. - Key Observations for the Week: - Fundamental factors (e.g., profitability) showed significant positive excess returns. - Stocks with high short-term momentum and high volatility outperformed. - Size-related factors (e.g., market capitalization) continued to underperform, indicating a preference for mid- to small-cap stocks. - Formula: Factor returns are calculated as the weighted average of stock returns within each style category. [23][24] - **Factor Evaluation**: The factors effectively capture shifts in market preferences, providing actionable insights for portfolio adjustments. [23][24] --- Factor Backtesting Results 1. Proprietary Active Trader Activity Indicator - **Key Metrics**: - Indicator showed consistent decline from late April, reflecting reduced risk appetite. - Recent marginal improvement suggests a potential rebound in speculative activity. [3][13] 2. BARRA Style Factors - **Key Metrics**: - Momentum: +0.2% weekly return. - Volatility: +0.2% weekly return. - Profitability: +0.3% weekly return. - Size: -0.5% weekly return. - Nonlinear Size: -0.3% weekly return. [23][24]
钢铁周报:需求季节性走弱,限产预期托底-20250608
ZHESHANG SECURITIES· 2025-06-08 13:04
Investment Rating - The industry investment rating is "Positive" [1] Core Viewpoints - Seasonal demand is weakening, but production restrictions are expected to provide support [1] - The report highlights that the overall inventory of five major steel products is 930 thousand tons, with a year-to-date increase of 22.7% [5] - The total inventory at steel mills is 433 thousand tons, reflecting a year-to-date increase of 23.6% [5] - Iron ore port inventory stands at 13.83 million tons, with a year-to-date increase of 6.9% [5] Price Data Summary - The SW Steel Index is at 2,119, with a weekly change of -0.2% and a year-to-date change of 0.8% [3] - Rebar (HRB400 20mm) price is 3,140 CNY/ton, with a weekly change of 0.3% and a year-to-date change of 7.9% [3] - Hot-rolled coil price is 3,230 CNY/ton, with a weekly change of 0.3% and a year-to-date change of 5.6% [3] - Cold-rolled steel price is 3,640 CNY/ton, with a weekly change of 2.8% and a year-to-date change of -11.4% [3] Supply and Demand Summary - The average daily pig iron output is projected to be around 230 thousand tons [9] - The report indicates that the apparent demand for rebar is measured in ten thousand tons [14]
智翔金泰(688443):赛立奇商业化,多管线兑现期
ZHESHANG SECURITIES· 2025-06-08 12:54
Investment Rating - The investment rating for the company is "Buy" [7] Core Views - The report is optimistic about the commercialization prospects of the company's products, including the monoclonal antibody "Sailiqi" and the bispecific antibody for rabies [1] - The company achieved significant revenue growth in 2024, with total revenue reaching 30.10 million yuan, and a slight narrowing of net losses compared to the previous year [1] - The company is advancing its pipeline with a focus on differentiated indications, with key products expected to enter commercialization phases [1][2] Financial Performance - In 2024, the company reported a revenue of 30.10 million yuan, a substantial increase from the previous year, while the net profit attributable to the parent company was a loss of 797.27 million yuan [4][6] - For Q1 2025, the company generated revenue of 20.16 million yuan, with a net loss of 121 million yuan [1] - Revenue projections for 2025 to 2027 are estimated at 199 million yuan, 533 million yuan, and 1.07 billion yuan respectively, indicating strong growth potential [4][6] Pipeline Development - The "Sailiqi" monoclonal antibody has received approvals for two indications, with expectations for significant sales growth in 2025 and 2026 [1] - The bispecific antibody GR1803 has entered a collaboration agreement with Cullinan Therapeutics, with a total transaction value of 712 million USD, currently in Phase II clinical trials [3] - Other pipeline products, including GR1802 and GR1801, are progressing through clinical trials, with GR1802 targeting multiple indications and GR1801 being a promising rabies treatment [2][3]
主动量化周报:6月中旬:边际乐观,逢低建仓-20250608
ZHESHANG SECURITIES· 2025-06-08 10:58
- The report suggests that the market is currently at a good point for building positions due to sufficient pessimistic expectations indicated by factors such as futures discount and reduced trading volume[1][10][11] - The report highlights that if the annualized discount of the CSI 500 index futures exceeds 15%, buying the CSI 500 index and holding it for more than 12 trading days can lead to average cumulative returns increasing, with a win rate exceeding 50% after 33 trading days and reaching about 60% after 50 trading days[1][11] - The report mentions that the public funds are inclined to adjust their benchmark to the CSI 800, which has higher allocations in pharmaceuticals, chemicals, and computers compared to the previous mainstream benchmark CSI 300, potentially bringing event-driven returns[2][12] - The report constructs a "active capital activity indicator" based on the Dragon and Tiger list data, which has been declining since the end of April, indicating a decrease in risk appetite among active funds, but has recently shown signs of marginal recovery[3][13] - The report monitors the activity of informed traders, noting that the informed trader activity indicator has been hovering near the zero line, suggesting a cautious attitude towards the market[15] - The report calculates the rolling 12-month ROE and net profit growth rate changes for Shenwan first-level industries, with industries like light manufacturing, building materials, and real estate showing significant growth in net profit expectations[18][19] - The report observes that the net inflow of margin trading funds this week is highest in the pharmaceutical and biological industry, with a net inflow of 2.69 billion yuan[20][21] - The report analyzes the performance of BARRA style factors, noting that fundamental-related factors have shown significant positive excess returns, and funds prefer growth over value in the short term[23][24] Quantitative Models and Construction Methods 1. **Model Name: Active Capital Activity Indicator** - **Construction Idea**: Based on Dragon and Tiger list data to measure the activity level of active funds - **Construction Process**: The indicator is constructed by tracking the trading activity of active funds listed on the Dragon and Tiger list, with a focus on their buying and selling behavior over time[3][13] - **Evaluation**: Indicates the risk appetite of active funds, useful for understanding market sentiment[3][13] 2. **Model Name: Informed Trader Activity Indicator** - **Construction Idea**: Measures the activity level of informed traders to gauge market sentiment - **Construction Process**: The indicator is constructed by analyzing the trading activity of informed traders, focusing on their buying and selling patterns and their impact on market movements[15] - **Evaluation**: Provides insights into the cautious or optimistic attitudes of informed traders towards the market[15] Quantitative Factors and Construction Methods 1. **Factor Name: Futures Discount Factor** - **Construction Idea**: Based on the annualized discount of the CSI 500 index futures - **Construction Process**: The factor is constructed by calculating the annualized discount of the CSI 500 index futures and analyzing its impact on the index's performance over different holding periods[1][11] - **Evaluation**: Historical data shows that a significant discount can indicate a good entry point for building positions[1][11] 2. **Factor Name: Industry ROE and Net Profit Growth Factor** - **Construction Idea**: Based on the rolling 12-month ROE and net profit growth rate changes for Shenwan first-level industries - **Construction Process**: The factor is constructed by calculating the rolling 12-month ROE and net profit growth rate changes for each industry, and identifying industries with significant growth[18][19] - **Evaluation**: Helps identify industries with strong growth potential and positive market expectations[18][19] Factor Backtesting Results 1. **Futures Discount Factor** - **Win Rate after 33 Trading Days**: >50%[1][11] - **Win Rate after 50 Trading Days**: ~60%[1][11] 2. **Industry ROE and Net Profit Growth Factor** - **Light Manufacturing Net Profit Growth**: 0.63%[18][19] - **Building Materials Net Profit Growth**: 0.56%[18][19] - **Real Estate Net Profit Growth**: 0.49%[18][19] Style Factor Performance 1. **Turnover**: -0.3%[24] 2. **Financial Leverage**: 0.0%[24] 3. **Earnings Volatility**: 0.3%[24] 4. **Earnings Quality**: 0.2%[24] 5. **Profitability**: 0.3%[24] 6. **Investment Quality**: 0.1%[24] 7. **Long-term Reversal**: 0.1%[24] 8. **EP Value**: -0.1%[24] 9. **BP Value**: 0.0%[24] 10. **Growth**: 0.1%[24] 11. **Momentum**: 0.2%[24] 12. **Non-linear Size**: -0.3%[24] 13. **Size**: -0.5%[24] 14. **Volatility**: 0.2%[24] 15. **Near-term Reversal**: 0.4%[24] 16. **Dividend Yield**: -0.1%[24]
可转债周度跟踪:仓位中性,择券为主-20250608
ZHESHANG SECURITIES· 2025-06-08 08:19
1. Report Industry Investment Rating - Not provided in the given content 2. Core Viewpoints of the Report - The market fluctuated upward this week, with major broad - based indices and convertible bond indices showing a mild recovery. The market's main line is still unclear, and it is waiting for incremental information. The convertible bond market resonated with the equity market, with increased trading activity and a continued differentiation in the valuation structure. The focus of capital allocation has shifted from extreme elasticity to high certainty, and a "stable allocation + selective elasticity" dual - wheel drive strategy is maintained. In the bond market, the pressure of maturing inter - bank certificates of deposit in the next three weeks is still large, and the pressure on cross - quarter liquidity cannot be ignored. It is difficult to see a smooth decline in interest rates in June [1][2]. - In the equity market, under the dual background of the adjustment of the public fund assessment mechanism and the phased easing of Sino - US tariffs, the main line is still unclear, and the style is differentiated. The dividend style has attracted wide attention, and the growth style is gradually recovering. The market value structure is biased towards small - cap growth. In terms of strategy, it is necessary to optimize strategies by combining new productive forces, institutional dividends, and the dynamic evolution of the valuation system. In terms of allocation, attention should be paid to the dividend, technology growth, and large - consumption sectors [8]. - For the convertible bond market, it is recommended to use a framework of "neutral position, bond selection as the foundation". The dumbbell strategy will still be dominant. In terms of allocation, focus on three directions: concentrating positions on high - rating, low - premium blue - chip convertible bonds; selecting medium - and high - priced thematic growth bonds; and conducting refined management in combination with clause events and credit marginal changes [2][9]. 3. Summary by Relevant Catalogs 3.1 Market Observation - In the past week (from June 2nd to June 6th), major broad - based indices and convertible bond indices fluctuated upward, but the market style was still differentiated. The convertible bond information technology index, AA - and below index, convertible bond high - price index, and small - cap convertible bond index led the gains. In the bond market, the pressure of maturing inter - bank certificates of deposit in the next three weeks is large, and it is difficult to see a smooth decline in interest rates in June [7]. - In the equity market, the main line is unclear, and the style is differentiated. The dividend style is popular, and the growth style is recovering. The market value structure is biased towards small - cap growth. Attention should be paid to the dividend, technology growth, and large - consumption sectors [8]. - The convertible bond market resonated with the equity market, showing a mild recovery, with increased trading activity and a continued differentiation in the valuation structure. A "stable allocation + selective elasticity" strategy is maintained, and a "neutral position, bond selection as the foundation" framework is recommended [9]. 3.2 Convertible Bond Market Tracking 3.2.1 Convertible Bond Market Conditions - The report provides the performance data of various convertible bond indices in different time periods, such as the one - week, two - week, 3 - month - since, one - month, two - month, half - year, and one - year changes of the Wind Convertible Bond Energy Index, Wind Convertible Bond Materials Index, etc. [10] 3.2.2 Convertible Bond Individual Bonds - The report shows the top five and bottom five individual bonds in terms of weekly price changes and the top five and bottom five underlying stocks of individual bonds in terms of weekly price changes, but specific bond names are not provided [13][25] 3.2.3 Convertible Bond Valuation - The report presents the valuation trends of bond - type, balanced, and equity - type convertible bonds, as well as the conversion premium rate valuation trends of convertible bonds with par values in different ranges (90 - 100, 100 - 110, 110 - 120) [19][21][31] 3.2.4 Convertible Bond Prices - The report shows the trends of the proportion of high - price bonds, low - price bonds, the proportion of bonds falling below the bond floor, and the median price of the convertible bond market [29][33]
食饮行业周报(2025年6月第1期):新消费关注催化,白酒探底茶饮入通
ZHESHANG SECURITIES· 2025-06-07 13:25
Investment Rating - The industry rating is "Positive" (maintained) [5] Core Views - The new consumption trend continues, focusing on low-priced/undervalued stocks with potential catalysts, particularly in the food and beverage sector. Key areas of focus include "category dividends in the food sector," "new channel drivers like membership supermarkets," and "new hotspots in health products" [2][16] - The traditional consumption represented by liquor may face pressure, with current recommendations for leading brands in the fragrance category [12][16] Summary by Sections Liquor Sector - The liquor sector is expected to face pressure in Q2, with current valuations remaining low. Recommended stocks include leading brands such as Guizhou Moutai, Wuliangye, and Shanxi Fenjiu for medium-term positioning [12][16] - Recent performance shows a decline of 0.84% in the liquor sector, with notable increases in stocks like Jinhui Liquor (+6.25%) and Huangtai Liquor (+5.03%) [3][22] - Guizhou Moutai has launched new products at the 2025 Osaka World Expo, indicating ongoing brand expansion efforts [4] Consumer Goods Sector - The consumer goods sector continues to show potential, with a focus on stocks like New Dairy, Jin Zai Food, and Aijia Food. The sector saw a rise in non-dairy beverages (+1.33%) and meat products (+1.30%) [2][22] - The overall market sentiment remains positive, with a recommendation for leading stocks in the retail transformation and cost cycle opportunities [16] Market Performance - From June 3 to June 6, the CSI 300 index rose by 0.88%, with the non-dairy beverage and meat product sectors leading the gains. In contrast, other liquor categories saw declines [22] - The valuation levels in the food and beverage industry have adjusted, with the industry trading at 21.64 times earnings, while specific segments like liquor are trading at varying multiples [28]
上海沿浦:下游客户放量、财务压力减小,25Q2公司有望出现业绩拐点-20250607
ZHESHANG SECURITIES· 2025-06-07 13:25
Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Insights - The company is expected to see a performance inflection point in Q2 2025 due to increased downstream customer demand and reduced financial pressure [1][9] - The company has introduced its "automotive seat business" in its annual report, indicating a significant market opportunity with low domestic replacement rates [3] - Revenue and profit forecasts for 2025-2027 show strong growth, with expected revenues of 33 billion, 43 billion, and 48 billion respectively, and net profits of 2.5 billion, 3.5 billion, and 4.5 billion [4] Summary by Sections Financial Performance - In Q1 2025, revenue decreased by approximately 24% due to weak downstream customer sales, particularly the significant drop in sales of the Wanjie M7 model [2] - The company's gross margin improved to 19%, a year-on-year increase of 6 percentage points, driven by a higher proportion of high-margin front-row products [2] - The company anticipates a total reduction of 455 million in cash outflows from financing from 2025 to 2028, along with a decrease in financial expenses by 72 million over the same period [2] Future Outlook - The company is positioned to benefit from the upcoming launches of the upgraded Wanjie M7 and the new M8 model, which are expected to significantly boost revenue in Q2 2025 [9] - The company is also exploring opportunities to become a supplier for rising automotive brands like Leap Motor, which is experiencing rapid sales growth [9] - The release of production capacity in Huizhou and Zhengzhou is expected to alleviate capacity constraints and enhance the company's core business performance [10]